Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Mar. 31, 2020 | May 15, 2020 | |
Document Information [Line Items] | ||
Entity Registrant Name | Yunhong International | |
Entity Central Index Key | 0001773086 | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Current Fiscal Year End Date | --06-30 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2020 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q3 | |
Entity Shell Company | true | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Class A ordinary shares | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 7,219,500 | |
Class B ordinary shares | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 1,725,000 |
CONDENSED BALANCE SHEETS
CONDENSED BALANCE SHEETS - USD ($) | Mar. 31, 2020 | Jun. 30, 2019 |
Current Assets | ||
Cash | $ 819,746 | $ 19 |
Prepaid expenses and other receivable | 29,663 | 0 |
Total Current Assets | 849,409 | 19 |
Deferred offering costs | 0 | 111,758 |
Cash and marketable securities held in Trust Account | 67,902,176 | 0 |
Total Assets | 68,751,585 | 111,777 |
Current Liabilities | ||
Accrued expenses | 59,416 | 708 |
Promissory note- related party | 210,659 | 91,150 |
Total Current Liabilities | 270,075 | 91,858 |
Deferred underwriting fees | 2,415,000 | 0 |
Total Liabilities | 2,685,075 | 91,858 |
Commitments and contingencies | ||
Class A ordinary shares subject to possible redemption, 6,106,650 shares at March 31, 2020 | 61,066,500 | 0 |
Shareholders' Equity | ||
Preference shares, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding | ||
Additional paid-in capital | 6,130,047 | 23,275 |
Accumulated deficit | (1,132,875) | (5,081) |
Total Shareholders' Equity | 5,000,010 | 19,919 |
Total Liabilities and Shareholders' Equity | 68,751,585 | 111,777 |
Class A ordinary shares | ||
Shareholders' Equity | ||
Class A ordinary shares, $0.001 par value; 47,000,000 shares authorized; 1,112,850 and 0 shares issued and outstanding (excluding 6,106,650 and 0 shares subject to possible redemption) at March 31, 2020 and June 30, 2019, respectively | 1,113 | 0 |
Class B ordinary shares, $0.001 par value; 2,000,000 shares authorized; 1,725,000 shares issued and outstanding at March 31, 2020 and June 30, 2019 | 1,113 | 0 |
Class B ordinary shares | ||
Shareholders' Equity | ||
Class A ordinary shares, $0.001 par value; 47,000,000 shares authorized; 1,112,850 and 0 shares issued and outstanding (excluding 6,106,650 and 0 shares subject to possible redemption) at March 31, 2020 and June 30, 2019, respectively | 1,725 | 1,725 |
Class B ordinary shares, $0.001 par value; 2,000,000 shares authorized; 1,725,000 shares issued and outstanding at March 31, 2020 and June 30, 2019 | $ 1,725 | $ 1,725 |
CONDENSED BALANCE SHEETS (Paren
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares | Mar. 31, 2020 | Jun. 30, 2019 |
Preference shares, par value | $ 0.001 | $ 0.001 |
Preference shares, shares authorized | 1,000,000 | 1,000,000 |
Preference shares, shares issued | 0 | 0 |
Preference shares, shares outstanding | 0 | 0 |
Class A ordinary shares | ||
Ordinary shares, par value | $ 0.001 | $ 0.001 |
Ordinary shares, shares authorized | 47,000,000 | 47,000,000 |
Ordinary shares, shares issued | 1,112,850 | 0 |
Ordinary shares, shares outstanding | 1,112,850 | 0 |
Ordinary shares, shares subject to possible redemption | 6,106,650 | 0 |
Class B ordinary shares | ||
Ordinary shares, par value | $ 0.001 | $ 0.001 |
Ordinary shares, shares authorized | 2,000,000 | 2,000,000 |
Ordinary shares, shares issued | 1,725,000 | 1,725,000 |
Ordinary shares, shares outstanding | 1,725,000 | 1,725,000 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 9 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | Mar. 31, 2020 | |
General and administrative expenses | $ 51,441 | $ 5,000 | $ 51,572 |
Loss from operations | (51,441) | (5,000) | (51,572) |
Other income (expense): | |||
Interest income earned on marketable securities held in the Trust Account | 75,369 | 0 | 75,369 |
Unrealized loss on marketable securities held in the Trust Account | (1,151,591) | 0 | (1,151,591) |
Total other expense, net | (1,076,222) | 0 | (1,076,222) |
Net loss | $ (1,127,663) | $ (5,000) | $ (1,127,794) |
Class A ordinary shares | |||
Other income (expense): | |||
Weighted average shares outstanding of Class A redeemable ordinary shares | 6,771,429 | 0 | 6,771,429 |
Basic and diluted net loss per share, Class A redeemable ordinary shares | $ (0.16) | $ 0 | $ (0.16) |
Weighted average shares outstanding of Class A and Class B non-redeemable ordinary shares | 6,771,429 | 0 | 6,771,429 |
Basic and diluted net loss per share, Class A and Class B non-redeemable ordinary shares | $ (0.16) | $ 0 | $ (0.16) |
Class A and Class B ordinary shares | |||
Other income (expense): | |||
Weighted average shares outstanding of Class A redeemable ordinary shares | 1,870,681 | 1 | 1,773,207 |
Basic and diluted net loss per share, Class A redeemable ordinary shares | $ (0.03) | $ 0 | $ (0.03) |
Weighted average shares outstanding of Class A and Class B non-redeemable ordinary shares | 1,870,681 | 1 | 1,773,207 |
Basic and diluted net loss per share, Class A and Class B non-redeemable ordinary shares | $ (0.03) | $ 0 | $ (0.03) |
CONDENSED STATEMENTS OF CHANGES
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) | Class A ordinary sharesOrdinary SharesInitial Public Offering | Class A ordinary sharesOrdinary SharesPrivate Placement | Class A ordinary sharesOrdinary Shares | Class B ordinary sharesOrdinary SharesInitial Public Offering | Class B ordinary sharesOrdinary SharesPrivate Placement | Class B ordinary sharesOrdinary Shares | Additional Paid-in CapitalInitial Public Offering | Additional Paid-in CapitalPrivate Placement | Additional Paid-in Capital | Accumulated DeficitInitial Public Offering | Accumulated DeficitPrivate Placement | Accumulated Deficit | Initial Public Offering | Private Placement | Total |
Beginning balance at Jan. 09, 2019 | $ 0 | $ 0 | $ 0 | $ 0 | |||||||||||
Beginning balance (in shares) at Jan. 09, 2019 | 0 | ||||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Issuance of Representative Shares | $ 0 | 0 | 0 | 0 | |||||||||||
Issuance of Representative Shares (in shares) | 1 | ||||||||||||||
Net loss | $ 0 | 0 | (5,000) | (5,000) | |||||||||||
Ending balance at Mar. 31, 2019 | $ 0 | 0 | (5,000) | (5,000) | |||||||||||
Ending balance (in shares) at Mar. 31, 2019 | 1 | ||||||||||||||
Beginning balance at Jun. 30, 2019 | $ 0 | $ 1,725 | 23,275 | (5,081) | 19,919 | ||||||||||
Beginning balance (in shares) at Jun. 30, 2019 | 0 | 1,725,000 | |||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Net loss | $ 0 | $ 0 | 0 | (131) | (131) | ||||||||||
Ending balance at Sep. 30, 2019 | $ 0 | $ 1,725 | 23,275 | (5,212) | 19,788 | ||||||||||
Ending balance (in shares) at Sep. 30, 2019 | 0 | 1,725,000 | |||||||||||||
Beginning balance at Jun. 30, 2019 | $ 0 | $ 1,725 | 23,275 | (5,081) | 19,919 | ||||||||||
Beginning balance (in shares) at Jun. 30, 2019 | 0 | 1,725,000 | |||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Net loss | (1,127,794) | ||||||||||||||
Ending balance at Mar. 31, 2020 | $ 1,113 | $ 1,725 | 6,130,047 | (1,132,875) | 5,000,010 | ||||||||||
Ending balance (in shares) at Mar. 31, 2020 | 1,112,850 | 1,725,000 | |||||||||||||
Beginning balance at Sep. 30, 2019 | $ 0 | $ 1,725 | 23,275 | (5,212) | 19,788 | ||||||||||
Beginning balance (in shares) at Sep. 30, 2019 | 0 | 1,725,000 | |||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Net loss | $ 0 | $ 0 | 0 | 0 | 0 | ||||||||||
Ending balance at Dec. 31, 2019 | $ 0 | $ 1,725 | 23,275 | (5,212) | 19,788 | ||||||||||
Ending balance (in shares) at Dec. 31, 2019 | 0 | 1,725,000 | |||||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||||
Sale of 6,900,000 Units, net of underwriting discounts and offering costs and Sale of 250,500 Private Units | $ 6,900 | $ 251 | $ 0 | $ 0 | $ 64,662,385 | $ 2,504,749 | $ 0 | $ 0 | $ 64,669,285 | $ 2,505,000 | |||||
Sale of 6,900,000 Units, net of underwriting discounts and offering costs/issuance of ordinary share and Sale of 250,500 Private Units (in shares) | 6,900,000 | 250,500 | 0 | 0 | |||||||||||
Issuance of Representative Shares | $ 69 | $ 0 | (69) | 0 | 0 | ||||||||||
Issuance of Representative Shares (in shares) | 69,000 | 0 | |||||||||||||
Sale of Unit Purchase Option | $ 0 | $ 0 | 100 | 0 | 100 | ||||||||||
Ordinary shares subject to possible redemption | $ (6,107) | $ 0 | (61,060,393) | 0 | (61,066,500) | ||||||||||
Ordinary shares subject to possible redemption (in shares) | (6,106,650) | 0 | |||||||||||||
Net loss | $ 0 | $ 0 | 0 | (1,127,663) | (1,127,663) | ||||||||||
Ending balance at Mar. 31, 2020 | $ 1,113 | $ 1,725 | $ 6,130,047 | $ (1,132,875) | $ 5,000,010 | ||||||||||
Ending balance (in shares) at Mar. 31, 2020 | 1,112,850 | 1,725,000 |
CONDENSED STATEMENTS OF CHANG_2
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) | Feb. 10, 2020 | Mar. 31, 2020shares |
Number of units sold in public offering | 6,900,000 | |
Number of units sold in private placement | 250,500 | |
Class B ordinary shares | ||
Stock dividend for each outstanding share | 1.20 |
CONDENSED STATEMENTS OF CASH FL
CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 3 Months Ended | 9 Months Ended |
Mar. 31, 2019 | Mar. 31, 2020 | |
Cash flows from operating activities: | ||
Net loss | $ (5,000) | $ (1,127,794) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Formation costs paid by Sponsor | 5,000 | 0 |
Interest earned on securities held in Trust Account | 0 | (75,369) |
Unrealized loss on securities held in Trust Account | 0 | 1,151,591 |
Fees charged to Trust Account | 0 | 21,602 |
Changes in operating assets and liabilities: | ||
Prepaid expenses and other receivable | 0 | (29,663) |
Accrued expenses | 0 | 58,708 |
Net cash used in operating activities | 0 | (925) |
Cash flows from investing activities: | ||
Investment of cash in Trust Account | 0 | (69,000,000) |
Net cash used in investing activities | 0 | (69,000,000) |
Cash flows from financing activities: | ||
Proceeds from sale of Units, net of underwriting discount paid | 0 | 67,620,000 |
Proceeds from sale of Private Units | 0 | 2,505,000 |
Proceeds from sale of unit purchase option | 0 | 100 |
Proceeds from promissory note - related party | 0 | 10,000 |
Payment of offering costs | 0 | (314,448) |
Net cash provided by financing activities | 0 | 69,820,652 |
Net change in cash | 0 | 819,727 |
Cash at beginning of period | 0 | 19 |
Cash at end of period | 0 | 819,746 |
Non-cash investing and financing activities: | ||
Initial classification of ordinary shares subject to possible redemption | 0 | 62,194,080 |
Change in value of ordinary shares subject to possible redemption | 0 | (1,127,580) |
Deferred underwriting fee payable | 0 | 2,415,000 |
Offering costs paid through promissory note - related party | 63,750 | 109,509 |
Issuance of Representative Shares | $ 0 | $ 69 |
DESCRIPTION OF ORGANIZATION AND
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | 9 Months Ended |
Mar. 31, 2020 | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Yunhong International (formerly known as China Yunhong Holdings) (the “Company”) is a blank check company incorporated in the Cayman Islands on January 10, 2019. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses that have their primary operations located in Asia (excluding China). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. At March 31, 2020, the Company had not yet commenced any operations. All activity through March 31, 2020 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”) (as discussed below) and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statements for the Company’s Initial Public Offering were declared effective on February 12, 2020. On February 18, 2020, the Company consummated the Initial Public Offering of 6,000,000 units (“Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $60,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 232,500 units (the “Private Units”) at a price of $10.00 per Private Unit in a private placement to the Company’s sponsor, LF International Pte. Ltd. (the “Sponsor”), generating gross proceeds of $2,325,000, which is described in Note 4. Following the closing of the Initial Public Offering on February 18, 2020, an amount of $60,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (“Trust Account”), until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Trust Account is controlled by the terms of the Investment Management Trust Agreement, dated February 12, 2020, by and between the Company and American Stock Transfer & Trust Company LLC, as the trustee (the “Trust Agreement”) (see Note 8 for additional information). On February 24, 2020, in connection with the underwriters’ election to fully exercise their over-allotment option, the Company consummated the sale of an additional 900,000 Units at $10.00 per Unit and the sale of an additional 18,000 Private Units at $10.00 per Private Unit, generating total gross proceeds of $9,180,000. Following the closing, an additional $9,000,000 was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $69,000,000. Transaction costs amounted to $ 4,330,715 , consisting of $1,380,000 of underwriting fees, $2,415,000 of deferred underwriting fees and $535,715 of other offering costs. In addition, as of March 31, 2020, cash of $819,746 was held outside of the Trust Account and is available for working capital purposes. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned and less any interest earned thereon that is released for taxes) at the time of signing a definitive agreement in connection with a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940 (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association, as amended, provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent. The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants or rights. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, as amended, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. The Sponsor has agreed (a) to vote its Class B ordinary shares, the Class A ordinary shares included in the Private Units (the “Private Shares”) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association, as amended, with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Class B ordinary shares) and Private Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Memorandum and Articles of Association, as amended, relating to shareholders’ rights of pre-Business Combination activity and (d) that the Class B ordinary shares and Private Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Company will have until February 18, 2021 to consummate a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination by February 18, 2021, the Company may extend the period of time to consummate a Business Combination up to three times, each by an additional three months (for a total of up to 21 months to complete a Business Combination) (the “Combination Period”). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees must deposit into the Trust Account $690,000 ($0.10 per share), on or prior to the applicable deadline for each three month extension (or up to an aggregate of $2,070,000, or $0.30 per share, if the Company extends for the full nine months). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than five business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.00 per share, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014‑15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 18, 2021. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Mar. 31, 2020 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10‑Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on February 14, 2020, as well as the Company’s Current Reports on Form 8‑K, as filed with the SEC on February 18, 2020 and February 24, 2020. The interim results for the three and nine months ended March 31, 2020 are not necessarily indicative of the results to be expected for year ending June 30, 2020 or for any future periods. Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of estimates The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2020 and June 30, 2019. Ordinary shares subject to possible redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s redeemable Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2020, ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. Offering costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounting to $4,330,715 were charged to shareholders’ equity upon the completion of the Initial Public Offering. Income taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of March 31, 2020 or June 30, 2019 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision is zero for the periods presented. Net loss per ordinary share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and the private placement to purchase 3,575,250 Class A ordinary shares, (2) rights sold in the Initial Public Offering and the private placement that convert into 715,050 Class A ordinary shares and (3) 345,000 Class A ordinary shares, warrants to purchase 172,500 Class A ordinary shares and rights that convert into 34,500 Class A ordinary shares in the unit purchase option sold to the underwriters, in the calculation of diluted loss per share, since the exercise of the warrants, the conversion of the rights into Class A ordinary shares and the exercise of the unit purchase option are contingent upon the occurrence of future events and inclusion of such warrants would be anti-dilutive under the treasury stock method. The Company’s condensed interim statements of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net loss per share, basic and diluted, for Class A redeemable ordinary shares is calculated by dividing the interest income earned and unrealized losses on the Trust Account of approximately $1,076,000 for the three and nine months ended March 31, 2020, by the weighted average number of Class A redeemable ordinary shares outstanding since original issuance. Net loss per share, basic and diluted, for Class A and B non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for loss attributable to Class A redeemable ordinary shares, by the weighted average number of Class A and B non-redeemable ordinary shares outstanding for the period. Class A and B non-redeemable ordinary shares includes the Private Units and Founder Shares (as defined in Note 5) as these shares do not have any redemption features and do not participate in the income or losses of the Trust Account. Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a foreign cash account in a financial institution. At March 31, 2020 and June 30, 2019, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair value of financial instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. Recently issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING | 9 Months Ended |
Mar. 31, 2020 | |
INITIAL PUBLIC OFFERING | |
INITIAL PUBLIC OFFERING | NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 6,900,000 Units at a purchase price of $10.00 per Unit, which includes the exercise by the underwriters of their over-allotment option in full of 900,000 Units at $10.00 per Unit. Each Unit consists of one Class A ordinary share, one-half of one redeemable warrant (“Public Warrant”) and one right (“Public Right”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7). Each Public Right entitles the holder to receive one-tenth of one Class A ordinary share upon the consummation of a Business Combination (see Note 7). |
PRIVATE PLACEMENT
PRIVATE PLACEMENT | 9 Months Ended |
Mar. 31, 2019 | |
PRIVATE PLACEMENT | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 232,500 Private Units at a price of $10.00 per Private Unit, or $2,325,000 in the aggregate. On February 24, 2020, in connection with the underwriters’ exercise of the over-allotment option in full, the Sponsor purchased an additional 18,000 Private Units for an aggregate purchase price of $180,000. Each Private Unit consists of one Private Share, one-half of one redeemable warrant (each, a “Private Warrant”) and one right (each, a “Private Right”). Each whole Private Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per whole share. Each Private Right entitles the holder to receive one-tenth of one Class A ordinary share upon the consummation of a Business Combination. The proceeds from the sale of the Private Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Warrants (and underlying securities) and Private Rights will expire worthless. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Mar. 31, 2020 | |
RELATED PARTY TRANSACTIONS | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In January 2019, the Company issued one Class B ordinary share to the Sponsor for no consideration. On May 23, 2019, the Company cancelled the one share and issued to the Sponsor 1,437,500 Class B ordinary shares (the “Founder Shares”) for an aggregate purchase price of $25,000, or approximately $0.017 per share. In February 2020, the Company effected a 1.2 for 1 stock dividend for each Founder Share outstanding, resulting in the Sponsor holding an aggregate of 1,725,000 Founder Shares, of which up to 225,000 shares were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, 225,000 Founder Shares are no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A ordinary shares equal or exceed $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Promissory Note – Related Party On May 23, 2019, the Company issued an unsecured promissory note to the Sponsor, as amended and restated on January 17, 2020 (the “Promissory Note”). Pursuant to the Promissory Note, the Company may borrow up to an aggregate principal amount of $300,000 to cover expenses related to the Initial Public Offering (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of June 30, 2020 or the completion of the Initial Public Offering. As of March 31, 2020, there was $210,659 outstanding under the Promissory Note. The Promissory Note is currently due on demand. Administrative Services Agreement The Company entered into an agreement, commencing on February 18, 2020 through the earlier of the consummation of a Business Combination or the Company’s liquidation, to pay the Sponsor a monthly fee of $10,000 for office space, administrative and support services. For the three and nine months ended March 31, 2020, the Company incurred $20,000 in fees for these services, of which $20,000 is included in accrued expenses in the accompanying condensed balance sheets. On April 15, 2020, the Company entered into an assignment agreement with the Sponsor and an affiliate of the Sponsor, pursuant to which all of the Sponsor’s rights and obligations under the agreement were assigned to the affiliate of the Sponsor. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be converted upon consummation of a Business Combination into additional units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The units would be identical to the Private Units. As of March 31, 2020 and June 30, 2019, no Working Capital Loans were outstanding. Related Party Extension Loans As discussed in Note 1, the Company may extend the period of time to consummate a Business Combination three times by an additional three months each time (for a total of 21 months to complete a Business Combination). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designee must deposit into the Trust Account for each three-month extension $690,000 ($0.10 per share), on or prior to the date of the applicable deadline. Any such payments would be made in the form of a loan and will be non-interest bearing and payable upon the consummation of a Business Combination. If the Company completes a Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. Up to $1,500,000 of such loans may be convertible into units at a price of $10.00 per unit at the option of the lender. If the Company does not complete a Business Combination, the Company will not repay such loans. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Mar. 31, 2020 | |
COMMITMENTS AND CONTINGENCIES | |
COMMITMENTS AND CONTINGENCIES | NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management is currently evaluating the impact of the COVID‑19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights Pursuant to a registration rights agreement entered into on February 12, 2020, the holders of the Founder Shares, the Private Units, securities underlying the unit purchase option issued to the underwriters and units that may be issued upon conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) , are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the Initial Public Offering, or $2,415,000. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement. Right of First Refusal For a period beginning on the closing of Initial Public Offering and ending 12 months from the closing of a Business Combination, the Company has granted the underwriters a right of first refusal to act as lead-left book running manager and lead left manager for any and all future private or public equity, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statements for the Initial Public Offering. |
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY | 9 Months Ended |
Mar. 31, 2020 | |
SHAREHOLDERS' EQUITY | |
SHAREHOLDERS' EQUITY | NOTE 7. SHAREHOLDERS’ EQUITY Preference Shares — The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2020 and June 30, 2019, there were no preferred shares issued or outstanding. Class A Ordinary Shares — The Company is authorized to issue 47,000,000 Class A ordinary shares with a par value of $0.001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At March 31, 2020, there were 1,112,850 Class A ordinary shares issued and outstanding, excluding 6,106,650 shares subject to possible redemption, respectively. At June 30, 2019, there were no Class A ordinary shares issued or outstanding. Class B Ordinary Shares — The Company is authorized to issue 2,000,000 Class B ordinary shares with a par value of $0.001 per share. At March 31, 2020 and June 30, 2019, there were 1,725,000 Class B ordinary shares issued and outstanding. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in Initial Public Offering and related to the closing of the Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of all ordinary shares outstanding upon completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination or any private placement-equivalent units issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their Class B ordinary shares into an equal number of Class A ordinary shares, subject to adjustment as provided above, at any time. Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the consummation of a Business Combination or (b) 12 months from the effective date of the registration statements for the Initial Public Offering. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such Class A ordinary shares. Notwithstanding the foregoing, if a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Company may call the warrants for redemption (excluding the Private Warrants but including any outstanding warrants issued upon exercise of the unit purchase option ): · in whole and not in part; · at a price of $0.01 per warrant; · upon not less than 30 days’ prior written notice of redemption (the “30‑day redemption period”) to each warrant holder; and · if, and only if, the reported last sale price of the Class A ordinary shares equal or exceed $16.50 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30‑trading day period ending on the third trading day prior to the date the Company sends to the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. If the Company calls the Public Warrants for redemption, management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the Class A ordinary shares issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Rights — Each holder of a right will receive one-tenth (1/10) of one Class A ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all Class A ordinary shares held by it in connection with a Business Combination. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination as the consideration related thereto has been included in the unit purchase price paid for by investors in the Initial Public Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the Class A ordinary shares will receive in the transaction on an as-converted into Class A ordinary share basis and each holder of a right will be required to affirmatively convert its rights in order to receive 1/10 share underlying each right (without paying additional consideration). The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman Islands law. As a result, the holders of the rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless. Representative Shares On February 18, 2020, the Company issued to the designees of the underwriters 60,000 Class A ordinary shares (the “Representative Shares”). On February 24, 2020, in connection with the underwriters’ election to exercise the over-allotment option in full, the Company issued an additional 9,000 Representative Shares to the designees of the underwriters. The Company accounted for the Representative Shares as an offering cost of the Initial Public Offering, with a corresponding credit to shareholders’ equity. The Company estimated the fair value of Representative Shares to be $690,000 based upon the price of the Units sold in the Initial Public Offering. The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of our initial business combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period. The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statements related to the Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. Unit Purchase Option On February 18, 2020, the Company sold to the underwriters (and its designees), for $100, an option to purchase up to 300,000 Units exercisable at $12.25 per Unit (or an aggregate exercise price of $4,226,250) commencing on the later of February 12, 2021 and the closing of a Business Combination. On February 24, 2020, in connection with the underwriters’ election to exercise the over-allotment option in full, the Company issued the underwriters an option to purchase up to an additional 45,000 Units exercisable at $12.25 per Unit for no additional consideration. The unit purchase option may be exercised for cash or on a cashless basis, at the holder’s option, and expires February 12, 2025. The Units issuable upon exercise of the option are identical to those offered in the Initial Public Offering. The Company accounted for the unit purchase option, inclusive of the receipt of $100 cash payment, as an expense of the Initial Public Offering resulting in a charge directly to shareholders’ equity. The Company estimated the fair value of the unit purchase option is approximately $893,000, or $2.59 per Unit, using the Black-Scholes option-pricing model. The fair value of the unit purchase option granted to the underwriters was estimated as of the date of grant using the following assumptions: (1) expected volatility of 35%, (2) risk-free interest rate of 1.39% and (3) expected life of five years. The option and such units purchased pursuant to the option, as well as the Class A ordinary shares underlying such units, the rights included in such units, the Class A ordinary shares that are issuable for the rights included in such units, the warrants included in such units, and the shares underlying such warrants, have been deemed compensation by FINRA and are therefore subject to a 180‑day lock-up pursuant to Rule 5110(g)(1) of FINRA’s NASDAQ Conduct Rules. Additionally, the option may not be sold, transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180‑day period) following the date of Initial Public Offering except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners. The option grants to holders demand and “piggy back” rights for periods of five and seven years, respectively, from the effective date of the registration statements with respect to the registration under the Securities Act of the securities directly and indirectly issuable upon exercise of the option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price and number of units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a stock dividend, or the Company’s recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of Class A ordinary shares at a price below its exercise price. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 9 Months Ended |
Mar. 31, 2020 | |
FAIR VALUE MEASUREMENTS | |
FAIR VALUE MEASUREMENTS | NOTE 8. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. At March 31, 2020, assets held in the Trust Account were comprised of $48,617,828 in mutual and money market funds, $14,092,999 in short maturity exchange-traded funds and $5,191,349 in U.S. Treasury Securities. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, Description Level 2020 Assets: Investments – Mutual and Money Market Fund 1 $ 48,617,828 Investments – Short Maturity Exchange-Traded Funds 1 $ 14,092,999 The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts. The gross holding losses and fair value of held-to-maturity securities at March 31, 2020 are as follows: Gross Amortized Holding Held-To-Maturity Cost Gains Fair Value March 31, 2020 U.S. Treasury Securities (Mature on 8/15/2020) $ 5,191,349 $ 18,419 $ 5,209,768 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Mar. 31, 2020 | |
SUBSEQUENT EVENTS | |
SUBSEQUENT EVENTS | NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Other than as described in these financial statements and below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. In connection with the preparation of this report for the quarter ended March 31, 2020, the Company determined that American Stock Transfer & Trust Company LLC, as the trustee, and Morgan Stanley, as custodian, had not invested the Trust Account funds in accordance with the Trust Agreement. Thereafter, the Company immediately took steps to liquidate such investments and to reinvest the funds only in the types of securities specified under the Trust Agreement (the date of such reinvestment, May 5, 2020, is referred to herein as the “Reinvestment Date”). As of March 31, 2020, the Company had an unrealized loss on marketable securities held in the Trust Account of $1,151,591 (including principal and interest). Between March 31, 2020 and the Reinvestment Date, the Company recouped part of the losses and on the Reinvestment Date the Company had an unrealized loss on marketable securities held in the Trust Account of $565,000 (the “Shortfall”). The Shortfall represents the difference between the aggregate amount of the funds in the Trust Account as of the Reinvestment Date and the amount that would have been in the Trust Account on the Reinvestment Date had the funds in the Trust Account always been invested pursuant to the requirements set forth in the Trust Agreement. To remedy the issue, and for no additional consideration, on May 14, 2020 the Sponsor funded the Trust Account in the amount of the Shortfall. The Company has engaged counsel and continues to explore its options relating to this matter |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Mar. 31, 2020 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Basis of presentation | Basis of presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10‑Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on February 14, 2020, as well as the Company’s Current Reports on Form 8‑K, as filed with the SEC on February 18, 2020 and February 24, 2020. The interim results for the three and nine months ended March 31, 2020 are not necessarily indicative of the results to be expected for year ending June 30, 2020 or for any future periods. |
Emerging growth company | Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of estimates | Use of estimates The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and cash equivalents | Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2020 and June 30, 2019. |
Ordinary shares subject to possible redemption | Ordinary shares subject to possible redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s redeemable Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2020, ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. |
Offering costs | Offering costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounting to $4,330,715 were charged to shareholders’ equity upon the completion of the Initial Public Offering. |
Income taxes | Income taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of March 31, 2020 or June 30, 2019 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision is zero for the periods presented. |
Net loss per ordinary share | Net loss per ordinary share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and the private placement to purchase 3,575,250 Class A ordinary shares, (2) rights sold in the Initial Public Offering and the private placement that convert into 715,050 Class A ordinary shares and (3) 345,000 Class A ordinary shares, warrants to purchase 172,500 Class A ordinary shares and rights that convert into 34,500 Class A ordinary shares in the unit purchase option sold to the underwriters, in the calculation of diluted loss per share, since the exercise of the warrants, the conversion of the rights into Class A ordinary shares and the exercise of the unit purchase option are contingent upon the occurrence of future events and inclusion of such warrants would be anti-dilutive under the treasury stock method. The Company’s condensed interim statements of operations includes a presentation of loss per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of loss per share. Net loss per share, basic and diluted, for Class A redeemable ordinary shares is calculated by dividing the interest income earned and unrealized losses on the Trust Account of approximately $1,076,000 for the three and nine months ended March 31, 2020, by the weighted average number of Class A redeemable ordinary shares outstanding since original issuance. Net loss per share, basic and diluted, for Class A and B non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for loss attributable to Class A redeemable ordinary shares, by the weighted average number of Class A and B non-redeemable ordinary shares outstanding for the period. Class A and B non-redeemable ordinary shares includes the Private Units and Founder Shares (as defined in Note 5) as these shares do not have any redemption features and do not participate in the income or losses of the Trust Account. |
Concentration of credit risk | Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a foreign cash account in a financial institution. At March 31, 2020 and June 30, 2019, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. |
Fair value of financial instruments | Fair value of financial instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. |
Recently issued accounting standards | Recently issued accounting standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 9 Months Ended |
Mar. 31, 2020 | |
FAIR VALUE MEASUREMENTS | |
Summary of information about the Company's assets that are measured at fair value on a recurring basis | March 31, Description Level 2020 Assets: Investments – Mutual and Money Market Fund 1 $ 48,617,828 Investments – Short Maturity Exchange-Traded Funds 1 $ 14,092,999 |
Summary of gross holding losses and fair value of held-to-maturity securities | Gross Amortized Holding Held-To-Maturity Cost Gains Fair Value March 31, 2020 U.S. Treasury Securities (Mature on 8/15/2020) $ 5,191,349 $ 18,419 $ 5,209,768 |
DESCRIPTION OF ORGANIZATION A_2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($) | Feb. 24, 2020 | Feb. 18, 2020 | Mar. 31, 2020 | Mar. 31, 2020 | Jun. 30, 2019 |
Number of units issued | 6,900,000 | ||||
Share Price | $ 9.20 | $ 9.20 | |||
Gross proceeds from issue of units | $ 9,180,000 | ||||
Amount deposited into trust account | 9,000,000 | $ 60,000,000 | |||
Aggregate proceeds held in the Trust Account | $ 69,000,000 | ||||
Transaction costs | $ 4,330,715 | $ 4,330,715 | |||
underwriting fees | 1,380,000 | ||||
Deferred underwriting fees | 2,415,000 | ||||
Other offering costs | 535,715 | ||||
Cash available for working capital purposes | 819,746 | 819,746 | $ 19 | ||
Minimum amount required for business acquisition | $ 5,000,001 | 5,000,001 | |||
Share price considered for redemption | $ 10 | ||||
Deposit in the trust account for business combination for three months extension | $ 690,000 | 690,000 | |||
Per share amount of deposit in the trust account for three months extension | $ 0.10 | ||||
Amount of deposit for nine months extension | $ 2,070,000 | 2,070,000 | |||
Per share amount of deposit for nine months extension | $ 0.30 | $ 0.30 | |||
Percentage of redemption of outstanding public shares if business combiantion not completed | 100.00% | ||||
Dissolution expenses | $ 50,000 | ||||
Minimum per share amount for sponser not liable | $ 10 | ||||
Initial Public Offering | |||||
Number of units issued | 6,000,000 | ||||
Share Price | $ 10 | $ 10 | $ 10 | ||
Gross proceeds from issue of units | $ 60,000,000 | $ 64,669,285 | |||
Private Placement | |||||
Number of units issued | 18,000 | 232,500 | |||
Share Price | $ 10 | $ 10 | |||
Gross proceeds from issue of units | $ 2,325,000 | $ 2,505,000 | |||
Over-allotment option | |||||
Number of units issued | 900,000 | 900,000 | |||
Share Price | $ 10 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) | 3 Months Ended | 9 Months Ended |
Mar. 31, 2020 | Mar. 31, 2020 | |
Offering costs | $ 4,330,715 | $ 4,330,715 |
Class A ordinary shares | ||
Net loss per ordinary share | ||
Interest income earned and unrealized losses on the Trust Account | $ 1,076,000 | $ 1,076,000 |
Class A ordinary shares | Unit Purchase Option | ||
Net loss per ordinary share | ||
Shares not considered for calculation of net loss per share | 345,000 | |
Warrants | Class A ordinary shares | Initial Public Offering and the private placement | ||
Net loss per ordinary share | ||
Shares not considered for calculation of net loss per share | 3,575,250 | |
Warrants | Class A ordinary shares | Unit Purchase Option | ||
Net loss per ordinary share | ||
Shares not considered for calculation of net loss per share | 172,500 | |
Rights | Class A ordinary shares | Initial Public Offering and the private placement | ||
Net loss per ordinary share | ||
Shares not considered for calculation of net loss per share | 715,050 | |
Rights | Class A ordinary shares | Unit Purchase Option | ||
Net loss per ordinary share | ||
Shares not considered for calculation of net loss per share | 34,500 |
INITIAL PUBLIC OFFERING (Detail
INITIAL PUBLIC OFFERING (Details) - $ / shares | Feb. 24, 2020 | Feb. 18, 2020 |
INITIAL PUBLIC OFFERING | ||
Number of units issued | 6,900,000 | |
Initial Public Offering | ||
INITIAL PUBLIC OFFERING | ||
Number of units issued | 6,000,000 | |
Unit price | $ 10 | |
Number of redeemable warrants per each unit | 0.5 | |
Number of public right for each unit | 1 | |
Initial Public Offering | Class A ordinary shares | ||
INITIAL PUBLIC OFFERING | ||
Number of shares per each unit | 1 | |
Number of shares per each public warrant | 1 | |
Exercise price of shares per each public warrant | $ 11.50 | |
Number of shares per each public right | 0.1 | |
Over-allotment option | ||
INITIAL PUBLIC OFFERING | ||
Number of units issued | 900,000 | 900,000 |
Unit price | $ 10 |
PRIVATE PLACEMENT (Details)
PRIVATE PLACEMENT (Details) - USD ($) | Feb. 24, 2020 | Feb. 18, 2020 | Mar. 31, 2020 |
PRIVATE PLACEMENT | |||
Number of units issued | 6,900,000 | ||
Share Price | $ 9.20 | ||
Gross proceeds from issue of units | $ 9,180,000 | ||
Private Placement | |||
PRIVATE PLACEMENT | |||
Number of units issued | 18,000 | 232,500 | |
Share Price | $ 10 | $ 10 | |
Gross proceeds from issue of units | $ 2,325,000 | $ 2,505,000 | |
Number of shares per each unit | 1 | ||
Number of redeemable warrants per each unit | 0.5 | ||
Number of private right for each unit | 1 | ||
Private Placement | Sponsor | |||
PRIVATE PLACEMENT | |||
Number of units issued | 18,000 | 232,500 | |
Share Price | $ 10 | ||
Gross proceeds from issue of units | $ 180,000 | $ 2,325,000 | |
Private Placement | Class A ordinary shares | |||
PRIVATE PLACEMENT | |||
Number of shares per each public warrant | 1 | ||
Exercise price of shares per each public warrant | $ 11.50 | ||
Number of shares per each public right | 0.1 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) | Feb. 24, 2020USD ($)shares | Feb. 18, 2020shares | May 23, 2019USD ($)$ / sharesshares | Feb. 29, 2020shares | Jan. 31, 2019USD ($)shares | Mar. 31, 2020D$ / shares | Mar. 31, 2020 |
Related Party Transaction [Line Items] | |||||||
Number of units issued | 6,900,000 | ||||||
Gross proceeds from issue of units | $ | $ 9,180,000 | ||||||
Number of shares held by sponsor | 1,725,000 | ||||||
Percentage of issued and outstanding shares after the Initial Public Offering held by the sponsor | 20.00% | ||||||
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination | 6 months | 30 days | |||||
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D | 20 | ||||||
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | 30 years | ||||||
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences | 150 days | ||||||
Class A ordinary shares | |||||||
Related Party Transaction [Line Items] | |||||||
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares | $ 12 | ||||||
Class B ordinary shares | |||||||
Related Party Transaction [Line Items] | |||||||
Number of shares held by sponsor subject to forfeiture | 225,000 | ||||||
Over-allotment option | |||||||
Related Party Transaction [Line Items] | |||||||
Number of units issued | 900,000 | 900,000 | |||||
Over-allotment option | Class B ordinary shares | |||||||
Related Party Transaction [Line Items] | |||||||
Number of units issued | 225,000 | ||||||
Sponsor | Class B ordinary shares | |||||||
Related Party Transaction [Line Items] | |||||||
Number of units issued | 1,437,500 | 1 | |||||
Gross proceeds from issue of units | $ | $ 25,000 | $ 0 | |||||
Number of shares issued to sponsor cancelled | 1 | ||||||
Capital Contribution by Sponsor Per Share | $ / shares | $ 0.017 | ||||||
Stock dividend | 1.2 |
RELATED PARTY TRANSACTIONS - Pr
RELATED PARTY TRANSACTIONS - Promissory Note (Details) - USD ($) | Feb. 18, 2020 | Jan. 17, 2020 | Mar. 31, 2020 | Mar. 31, 2020 |
Related Party Transaction [Line Items] | ||||
Office space, administrative and support services expenses per month | $ 20,000 | $ 20,000 | ||
Accrued Office space, administrative and support services expenses per month | 20,000 | $ 20,000 | ||
Sponsor Loans | ||||
Related Party Transaction [Line Items] | ||||
Amounts of transaction | $ 300,000 | |||
Proceeds from related party loan | $ 210,659 | |||
Administrative Services Agreement | ||||
Related Party Transaction [Line Items] | ||||
Office space, administrative and support services expenses per month | $ 10,000 |
RELATED PARTY TRANSACTIONS - Re
RELATED PARTY TRANSACTIONS - Related Party Extension Loans (Details) | 3 Months Ended | |
Mar. 31, 2020USD ($)item$ / shares | Jun. 30, 2019USD ($) | |
Related Party Transaction [Line Items] | ||
Number of times to extend the period of time to consummate a Business Combination | item | 3 | |
Extension period of time to consummate a Business Combination | 3 months | |
Total period to complete a Business Combination | 21 months | |
Deposit in the trust account for business combination for three months extension | $ 690,000 | |
Per share amount of deposit in the trust account for three months extension | $ / shares | $ 0.10 | |
Outstanding working capital loans | $ 0 | $ 0 |
Related Party Loans | ||
Related Party Transaction [Line Items] | ||
Loans convertible into warrants | $ 1,500,000 | |
Price of warrants (in dollars per share) | $ / shares | $ 10 | |
Related Party Extension Loans | ||
Related Party Transaction [Line Items] | ||
Loans convertible into warrants | $ 1,500,000 | |
Price of warrants (in dollars per share) | $ / shares | $ 10 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) - USD ($) | 9 Months Ended | |
Mar. 31, 2020 | Jun. 30, 2019 | |
COMMITMENTS AND CONTINGENCIES | ||
Deferred Fee as a percent of gross offering proceeds | 3.50% | |
Deferred Fee | $ 2,415,000 | $ 0 |
Term for right of first refusal | 12 months |
SHAREHOLDERS' EQUITY (Details)
SHAREHOLDERS' EQUITY (Details) (Imported) - $ / shares | Mar. 31, 2020 | Jun. 30, 2019 |
SHAREHOLDERS' EQUITY | ||
Preferred shares, shares authorized | 1,000,000 | 1,000,000 |
Preferred shares, par value | $ 0.001 | $ 0.001 |
Preferred shares, shares issued | 0 | 0 |
Preferred shares, shares outstanding | 0 | 0 |
SHAREHOLDERS' EQUITY - Ordinary
SHAREHOLDERS' EQUITY - Ordinary Shares (Details) (Imported) | 3 Months Ended | |
Mar. 31, 2020Vote$ / sharesshares | Jun. 30, 2019$ / sharesshares | |
Class of Stock [Line Items] | ||
Number of Class A common stock issued upon conversion of each share (in shares) | 1 | |
Number of common stock issuable pursuant to Initial Business Combination, as a percent of outstanding shares | 20.00% | |
Class A ordinary shares | ||
Class of Stock [Line Items] | ||
Common shares, shares authorized | 47,000,000 | 47,000,000 |
Common shares, par value | $ / shares | $ 0.001 | $ 0.001 |
Common shares, votes per share | Vote | 1 | |
Common shares, shares issued | 1,112,850 | 0 |
Common shares, shares outstanding | 1,112,850 | 0 |
Common shares, shares subject to possible redemption (in shares) | 6,106,650 | 0 |
Class B ordinary shares | ||
Class of Stock [Line Items] | ||
Common shares, shares authorized | 2,000,000 | 2,000,000 |
Common shares, par value | $ / shares | $ 0.001 | $ 0.001 |
Common shares, shares issued | 1,725,000 | 1,725,000 |
Common shares, shares outstanding | 1,725,000 | 1,725,000 |
SHAREHOLDERS' EQUITY - Warrants
SHAREHOLDERS' EQUITY - Warrants (Details) (Imported) | 3 Months Ended | 9 Months Ended |
Mar. 31, 2020$ / sharesshares | Mar. 31, 2020$ / sharesshares | |
SHAREHOLDERS' EQUITY | ||
Warrants exercisable term from the closing of the public offering | 12 months | |
Warrants expiration term | 5 years | 5 years |
Threshold period for filling registration statement after business combination | 15 days | |
Threshold period for filling registration statement within number of days of business combination | 60 days | |
Warrants exercisable for cash | shares | 0 | 0 |
Redemption price per warrant | $ 0.01 | $ 0.01 |
Minimum threshold written notice period for redemption of public warrants | 30 days | |
Stock price trigger for redemption of public warrants (in dollars per share) | 16.50 | $ 16.50 |
Closing price of share for threshold trading days | 20 days | |
Closing price of share for threshold consecutive trading days | 30 days | |
Price per share | $ 9.20 | $ 9.20 |
Percentage of gross proceeds on total equity proceeds | 60.00% | |
Adjustment of exercise price of warrants based on market value (as a percent) | 115.00% | 115.00% |
Adjustment of redemption price of stock based on market value (as a percent) | 180.00% | 180.00% |
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination | 6 months | 30 days |
SHAREHOLDERS' EQUITY - Rights (
SHAREHOLDERS' EQUITY - Rights (Details) (Imported) | Mar. 31, 2020USD ($)shares |
Class of Stock [Line Items] | |
Contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination | $ | $ 0 |
Class A ordinary shares | |
Class of Stock [Line Items] | |
Right to be received per common stock | shares | 0.1 |
SHAREHOLDERS' EQUITY - Represen
SHAREHOLDERS' EQUITY - Representative Shares (Details) (Imported) - USD ($) | Feb. 24, 2020 | Feb. 18, 2020 |
Class of Stock [Line Items] | ||
Number of units issued | 6,900,000 | |
Over-allotment option | ||
Class of Stock [Line Items] | ||
Number of units issued | 900,000 | 900,000 |
Representative Shares | ||
Class of Stock [Line Items] | ||
Number of units issued | 60,000 | |
Fair value of shares issued | $ 690,000 | |
Representative Shares | Over-allotment option | ||
Class of Stock [Line Items] | ||
Number of units issued | 9,000 |
SHAREHOLDERS' EQUITY - Unit Pur
SHAREHOLDERS' EQUITY - Unit Purchase Option (Details) (Imported) | Feb. 24, 2020shares | Feb. 18, 2020USD ($)$ / sharesshares |
Class of Stock [Line Items] | ||
Unit price | $ / shares | $ 100 | |
Maximum number of units authorized to issue | shares | 300,000 | |
Exercise price per unit | $ / shares | $ 12.25 | |
Aggregate exercise price value | $ | $ 4,226,250 | |
Number of units issued during period | shares | 45,000 | |
Fair value of the unit purchase option | $ | $ 893,000 | |
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination | 1 year | |
Holders demand period | 5 years | |
Holders piggy back period | 7 years | |
Fair value of unit | ||
Class of Stock [Line Items] | ||
Measurement peirod | $ / shares | 2.59 | |
Expected volatility | ||
Class of Stock [Line Items] | ||
Measurement peirod | 35 | |
Risk-free interest rate | ||
Class of Stock [Line Items] | ||
Measurement peirod | 1.39 | |
Expected life | ||
Class of Stock [Line Items] | ||
Measurement peirod | $ | 5 |
FAIR VALUE MEASUREMENTS (Detail
FAIR VALUE MEASUREMENTS (Details) | Mar. 31, 2020USD ($) |
Mutual and money market funds | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
Assets held in the Trust Account | $ 48,617,828 |
Short maturity exchange-traded funds | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
Assets held in the Trust Account | 14,092,999 |
U.S. Treasury Securities | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
Assets held in the Trust Account | $ 5,191,349 |
FAIR VALUE MEASUREMENTS - Inves
FAIR VALUE MEASUREMENTS - Investments (Details) - Recurring - Level 1 | Mar. 31, 2020USD ($) |
Mutual and money market funds | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Investments | $ 48,617,828 |
Short maturity exchange-traded funds | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Investments | $ 14,092,999 |
FAIR VALUE MEASUREMENTS - Addit
FAIR VALUE MEASUREMENTS - Additional Information (Details) - U.S. Treasury Securities | Mar. 31, 2020USD ($) |
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract] | |
Amortized Cost | $ 5,191,349 |
Gross Holding Gains | 18,419 |
Fair Value | $ 5,209,768 |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) - USD ($) | May 05, 2020 | Mar. 31, 2020 | Mar. 31, 2019 | Mar. 31, 2020 |
Subsequent Event [Line Items] | ||||
Unrealized loss on securities held in Trust Account | $ (1,151,591) | $ 0 | $ (1,151,591) | |
Subsequent event | ||||
Subsequent Event [Line Items] | ||||
Unrealized loss on securities held in Trust Account | $ 565,000 |